TED is NOT DEAD...testing for peanuts could bring £`s

Charts

Long Term Chart

Fundamental Data

Sector   HEALTH CARE EQUIPMENT & SERVICES   Mkt.Sector   AIM   Mkt.Segment   AIM   Turnover   18.34   Profit   1.27   Norm EPS   0.54   PE Ratio   20.83   Market cap   25.91   NMS   -

News

26/11/08 15:13 RNSNON

Tepnel Life...Ah! there we go again.

Worth while researching I would suggest.



grahambr, summed it up on 30/12/03:

clocktower
Look at MIDAS's posts for techy info and of course the tepnel web site www.tepnel.co.uk . Recent info is that there were two share issues one at 16p and then another out of the blue at 11.5p. However it must be realised that Directors bought big time on the 11.5p so read into this what you want. Also Tepnel are are on the front line with allergy detection kits (eg peanut allergy) and DNA processing. They are working on a new machine T3000 which is what the first share issue was for. Also they have bought an American distribution company placed strategicly both Geographicly an Intellectually Orchid Diagnostics which was the reason for the second placing.
Those of us supporting the company believe we are due for very good growth from here on.
Sorry if not entirely accurate but thats the jist of it.

Followed by Nobbygnome`s post 30/12/03:
The increase in buying volume in the last few days is very encouraging IMHO. I think there will be a lot of buyers ahead of the peanut test launch and the news of more T2000 sales. This is the year that TED will become profitable (IMHO) and so is a steal at 11.75p or a market cap of only £15 million.

Nobby

These posts sum the situation up well imo, so I leave it there for comments and wish all well in 2004.

Hope you all turn peanuts to pounds. Good Trading.